Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen-Reference-Cited by-同舟云学术

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

Published:1995-06 Issue:6 Volume:31 Page:876-881
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Atzpodien J.,Lopez Hänninen E.,Kirchner H.,Franzke A.,Körfer A.,Volkenandt M.,Duensing S.,Schomburg A.,Chaitchik S.,Poliwoda H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Combination phase I–II study of imidazole carboxamide (NCS 45388);Wagner;Oncology,1971

2. Results with methyl-CCNU and DTIC in metastatic melanoma;Costanza;Cancer,1977

3. Phase II evaluation of 1,3,-bis(2chloroethyl-nitrosurea) (BCNU; NSC-409962) in patients with solid tumors;Ramirez;Cancer Chemother Rep,1972

4. Cisplatin hydration with and withour mannitol diuresis in refractory disseminated malignant melanoma: a Southwest Oncology Group study;Al-Sarraf;Cancer Treat Rep,1982

5. Phase II trial of carboplatin in advanced malignant melanoma;Evans;Cancer Treat Rep,1987

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic treatments for metastatic cutaneous melanoma;Cochrane Database of Systematic Reviews;2018-02-06

2. Current and emerging treatment options for uveal melanoma;Clinical Ophthalmology;2013-08

3. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02

4. Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis;Clinical and Developmental Immunology;2010

5. Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis;Ophthalmology;2009-11